Form 8-K - Current report:
SEC Accession No. 0001104659-24-083955
Filing Date
2024-07-30
Accepted
2024-07-30 16:01:45
Documents
15
Period of Report
2024-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420401d1_8k.htm   iXBRL 8-K 26259
2 EXHIBIT 99.1 tm2420401d1_ex99-1.htm EX-99.1 7995
6 GRAPHIC tm2420401d1_e99-1img001.jpg GRAPHIC 7462
  Complete submission text file 0001104659-24-083955.txt   220392

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA swtx-20240726.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20240726_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20240726_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2420401d1_8k_htm.xml XML 3571
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 241157253
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)